Tag: HiPoint catheters
Route 92 announces new data on HiPoint reperfusion system alongside SUMMIT...
Route 92 Medical has today announced results from an independent, real-world study evaluating reperfusion outcomes following use of the company’s HiPoint reperfusion system—described by...
Route 92 announces presentation of SUMMIT MAX results and gains new...
Today, Route 92 Medical has announced positive results from its SUMMIT MAX randomised controlled trial (RCT) comparing the efficacy and safety of the HiPoint...
Route 92 gains Australian TGA approval for neurovascular interventional portfolio
Route 92 Medical has announced approval from the Australian Therapeutic Goods Administration (TGA) for its portfolio of innovative neurovascular interventional products intended to treat...
Route 92 completes enrolment in 250-patient SUMMIT MAX trial
Route 92 Medical has today announced the completion of enrolment in the 250-patient SUMMIT MAX clinical trial evaluating the safety and effectiveness of its...
